Cellectis (CLLS) Interest & Investment Income (2022 - 2026)

Cellectis' (CLLS) quarterly Interest & Investment Income came in at $11.9 million in Q1 2026, up 88.84% year-on-year from $6.3 million in Q1 2025, and up 489.93% quarter-over-quarter from $2.0 million in Q4 2025.

Cellectis (CLLS) Interest & Investment Income (2022 - 2026) Analysis & Trends

Cellectis' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $11.9 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income rose 88.84% year-over-year to $11.9 million in Q1 2026; TTM through Mar 2026 was $22.9 million, a 29.36% decrease from a year earlier, with the FY2025 full-year figure at $16.1 million, down 63.69% from the prior year.
  • Interest & Investment Income rose to $11.9 million in Q1 2026 per CLLS's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $29.4 million in Q1 2024 and bottomed at -$6.3 million in Q4 2022.
  • The 5-year median for Interest & Investment Income is $5.3 million (2023), against an average of $6.8 million.
  • Across the five-year window, Interest & Investment Income jumped 3694.84% in 2024 and sank 86.27% in 2025, its largest moves.
  • Year by year, Interest & Investment Income stood at -$6.3 million in 2022, then surged by 185.15% to $5.3 million in 2023, then soared by 174.6% to $14.7 million in 2024, then sank by 86.27% to $2.0 million in 2025, then surged by 489.93% to $11.9 million in 2026.
  • Per Business Quant, the three latest CLLS Interest & Investment Income figures stand at $11.9 million (Q1 2026), $2.0 million (Q4 2025), and $3.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Cellectis 285.50 Mn 99.83 Mn - 11.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.89 Mn
Dec 31, 2025 2.02 Mn
Sep 30, 2025 3.46 Mn
Jun 30, 2025 5.55 Mn
Mar 31, 2025 6.30 Mn
Dec 31, 2024 14.68 Mn
Sep 30, 2024 3.06 Mn
Jun 30, 2024 8.40 Mn
Mar 31, 2024 29.41 Mn
Dec 31, 2023 5.35 Mn
Sep 30, 2023 4.92 Mn
Jun 30, 2023 10.44 Mn
Mar 31, 2023 775,000.00
Dec 31, 2022 -6.28 Mn
Sep 30, 2022 2.90 Mn
Jun 30, 2022 9.99 Mn
Mar 31, 2022 2.27 Mn